The pragmatic use of apomorphine at the end of life.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 19837701.
- Also identified by DOI 10.1177/0269216309106979.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Parkinson's Disease (PD) is an irreversible degenerative neurological disorder with no known cure. Apomorphine is a potent short-acting D1/D2 dopamine agonist administered sub-cutaneously that is used in the treatment of PD. Optimising PD medication is an important aspect of end of life care. There are no previously reported cases of apomorphine providing symptom relief in terminal care of PD patients. This case highlights its potential benefits for symptom control at the end of life.
Medical subject headings
- Antiparkinson Agents
- Apomorphine
- Parkinson Disease
- Terminal Care